Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs.

PubWeight™: 1.82‹?› | Rank: Top 3%

🔗 View Article (PMC 128044)

Published in Infect Immun on July 01, 2002

Authors

Angelika Felk1, Marianne Kretschmar, Antje Albrecht, Martin Schaller, Sabine Beinhauer, Thomas Nichterlein, Dominique Sanglard, Hans C Korting, Wilhelm Schäfer, Bernhard Hube

Author Affiliations

1: Institut für Allgemeine Botanik, AMPIII, Universität Hamburg, D-22609 Hamburg, Germany.

Articles citing this

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev (2003) 4.07

Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev (2007) 2.71

Identification and characterization of a Candida albicans mating pheromone. Mol Cell Biol (2003) 2.42

Candida albicans cell wall proteins. Microbiol Mol Biol Rev (2008) 2.11

Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell (2003) 1.98

Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev (2011) 1.90

Lipid raft polarization contributes to hyphal growth in Candida albicans. Eukaryot Cell (2004) 1.82

Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell Microbiol (2008) 1.76

Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun (2007) 1.59

Candida albicans septin mutants are defective for invasive growth and virulence. Infect Immun (2003) 1.58

Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology (2008) 1.52

The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun (2003) 1.49

Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog (2013) 1.35

Genome-wide single-nucleotide polymorphism map for Candida albicans. Eukaryot Cell (2004) 1.31

Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence. Cell Microbiol (2009) 1.18

Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis. J Infect Dis (2013) 1.16

Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infect Immun (2013) 1.11

Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun (2010) 1.09

Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes. Eukaryot Cell (2012) 1.06

Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother (2003) 1.06

Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis. J Pathog (2014) 1.03

Cdc42p GTPase regulates the budded-to-hyphal-form transition and expression of hypha-specific transcripts in Candida albicans. Eukaryot Cell (2004) 0.98

Glucose sensing network in Candida albicans: a sweet spot for fungal morphogenesis. Eukaryot Cell (2009) 0.97

Pathogen and host factors are needed to provoke a systemic host response to gastrointestinal infection of Drosophila larvae by Candida albicans. Dis Model Mech (2011) 0.95

The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils. Infect Immun (2009) 0.95

In vivo systematic analysis of Candida albicans Zn2-Cys6 transcription factors mutants for mice organ colonization. PLoS One (2011) 0.93

Hgc1 mediates dynamic Candida albicans-endothelium adhesion events during circulation. Eukaryot Cell (2009) 0.91

Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes. J Clin Microbiol (2004) 0.90

Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis. Infect Immun (2015) 0.88

Induction of SAP7 correlates with virulence in an intravenous infection model of candidiasis but not in a vaginal infection model in mice. Infect Immun (2005) 0.88

Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin Diagn Lab Immunol (2003) 0.88

Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol (2003) 0.87

Human serum promotes Candida albicans biofilm growth and virulence gene expression on silicone biomaterial. PLoS One (2013) 0.86

Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans. BMC Microbiol (2008) 0.85

Cellular and molecular biology of Candida albicans estrogen response. Eukaryot Cell (2006) 0.85

A 5' UTR-mediated translational efficiency mechanism inhibits the Candida albicans morphological transition. Mol Microbiol (2014) 0.85

Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother (2012) 0.83

Morphogenic and genetic differences between Candida albicans strains are associated with keratomycosis virulence. Mol Vis (2009) 0.82

Regulated proteolysis of Candida albicans Ras1 is involved in morphogenesis and quorum sensing regulation. Mol Microbiol (2013) 0.81

Loss of heterozygosity at an unlinked genomic locus is responsible for the phenotype of a Candida albicans sap4Δ sap5Δ sap6Δ mutant. Eukaryot Cell (2010) 0.80

Evolutionary Selection on Barrier Activity: Bar1 Is an Aspartyl Protease with Novel Substrate Specificity. MBio (2015) 0.78

β-1,2-Mannosyltransferases 1 and 3 Participate in Yeast and Hyphae O- and N-Linked Mannosylation and Alter Candida albicans Fitness During Infection. Open Forum Infect Dis (2015) 0.78

Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. J Transl Med (2006) 0.78

Effects of surface reaction-type pre-reacted glass ionomer on oral biofilm formation of Streptococcus gordonii. Odontology (2015) 0.77

Global Identification of Biofilm-Specific Proteolysis in Candida albicans. MBio (2016) 0.77

HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos. World J Biol Chem (2010) 0.77

Sap6, a secreted aspartyl proteinase, participates in maintenance the cell surface integrity of Candida albicans. J Biomed Sci (2013) 0.77

Impact of glucose levels on expression of hypha-associated secreted aspartyl proteinases in Candida albicans. J Biomed Sci (2014) 0.77

Identification and characterization of Cor33p, a novel protein implicated in tolerance towards oxidative stress in Candida albicans. Eukaryot Cell (2005) 0.76

Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework. Infect Immun (2016) 0.76

Candida albicans morphologies revealed by scanning electron microscopy analysis. Braz J Microbiol (2013) 0.76

Transcriptional Profiling of Candida albicans in the Host. Methods Mol Biol (2016) 0.75

Candida albicans OPI1 regulates filamentous growth and virulence in vaginal infections, but not inositol biosynthesis. PLoS One (2015) 0.75

Differences in proteolytic activity and gene profiles of fungal strains isolated from the total parenteral nutrition patients. Folia Microbiol (Praha) (2011) 0.75

Overexpression of Candida albicans Secreted Aspartyl Proteinases 2 or 5 is not sufficient for exacerbation of immunopathology in a murine model of vaginitis. Infect Immun (2017) 0.75

Articles cited by this

Isogenic strain construction and gene mapping in Candida albicans. Genetics (1993) 17.18

Nonfilamentous C. albicans mutants are avirulent. Cell (1997) 13.83

Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet (1984) 11.51

Putative virulence factors of Candida albicans. Annu Rev Microbiol (1991) 4.85

Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J (1997) 4.82

The glyoxylate cycle is required for fungal virulence. Nature (2001) 4.70

The ALS gene family of Candida albicans. Trends Microbiol (2001) 3.93

CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast (2000) 3.34

Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol (1994) 3.23

Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol (1999) 3.06

Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science (1998) 3.04

Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun (1995) 2.75

Transcription factors in Candida albicans - environmental control of morphogenesis. Microbiology (2000) 2.74

Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun (1998) 2.51

A characterization of pH-regulated dimorphism in Candida albicans. Mycopathologia (1984) 2.47

A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun (1997) 2.35

Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun (1997) 2.24

Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol (1994) 2.09

Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun (2000) 1.93

Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol (1995) 1.88

Candida albicans proteinases: resolving the mystery of a gene family. Microbiology (2001) 1.74

Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol (1998) 1.70

Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol (2000) 1.70

Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69

In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun (1999) 1.68

Gene regulation during high-frequency switching in Candida albicans. Microbiology (1997) 1.67

Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci U S A (2000) 1.65

The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol (1998) 1.58

Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis (1999) 1.58

Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol (1998) 1.53

Adhesins in Candida albicans. Curr Opin Microbiol (1999) 1.42

Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology (1998) 1.35

Contact sensing in Candida albicans: a possible aid to epithelial penetration. J Med Vet Mycol (1992) 1.31

Growth kinetics and morphology of colonies of the filamentous form of Candida albicans. J Gen Microbiol (1982) 1.26

Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun (1999) 1.22

Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb Pathog (2002) 1.15

Purified Candida albicans proteinase in the serological diagnosis of systemic candidosis. JAMA (1980) 1.09

Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase Cpp1p of Candida albicans is independent of the MAP kinase Cek1p. Infect Immun (2000) 1.04

Candidiasis visualised by proteinase-directed immunofluorescence. Virchows Arch A Pathol Anat Histopathol (1991) 1.01

Molecular cloning and characterization of a Candida albicans gene (EFB1) coding for the elongation factor EF-1 beta. FEMS Microbiol Lett (1996) 0.98

Migration of the fungal pathogen Candida albicans across endothelial monolayers. Infect Immun (1996) 0.97

Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim Biophys Acta (2000) 0.96

Articles by these authors

Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature (2009) 5.90

T-helper-1-cell cytokines drive cancer into senescence. Nature (2013) 4.47

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev (2003) 4.07

A human-curated annotation of the Candida albicans genome. PLoS Genet (2005) 3.04

Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem (2005) 3.02

Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol (2005) 3.00

TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell (2004) 2.61

Candida albicans pathogenicity mechanisms. Virulence (2013) 2.60

A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics (2006) 2.54

Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med (2010) 2.51

In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell Microbiol (2007) 2.35

Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31

Infection patterns in barley and wheat spikes inoculated with wild-type and trichodiene synthase gene disrupted Fusarium graminearum. Proc Natl Acad Sci U S A (2005) 2.29

Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell (2007) 2.25

A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol (2002) 2.14

Stage-specific gene expression of Candida albicans in human blood. Mol Microbiol (2003) 1.97

Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses (2005) 1.96

the hyphal-associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host ferritin. PLoS Pathog (2008) 1.94

The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun (2002) 1.91

Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med (2010) 1.86

Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother (2004) 1.86

Bartonella adhesin a mediates a proangiogenic host cell response. J Exp Med (2004) 1.84

Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol (2009) 1.77

Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem (2005) 1.77

Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog (2009) 1.76

CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol (2006) 1.74

Candida albicans proteinases and host/pathogen interactions. Cell Microbiol (2004) 1.73

Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol (2002) 1.72

In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolates identifies genes associated with tissue invasion. Mol Microbiol (2007) 1.68

Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest (2007) 1.67

Human defensins. J Mol Med (Berl) (2005) 1.66

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol (2002) 1.66

A secreted lipase of Fusarium graminearum is a virulence factor required for infection of cereals. Plant J (2005) 1.63

Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol (2011) 1.62

From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One (2011) 1.54

Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology (2008) 1.52

Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol (2012) 1.50

Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. Eur J Immunol (2012) 1.50

The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun (2003) 1.49

Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol (2007) 1.40

Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr Opin Microbiol (2010) 1.39

Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob Agents Chemother (2010) 1.39

An Interspecies Regulatory Network Inferred from Simultaneous RNA-seq of Candida albicans Invading Innate Immune Cells. Front Microbiol (2012) 1.35

Candida albicans iron acquisition within the host. FEMS Yeast Res (2009) 1.35

Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther (2012) 1.34

Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi. Genome Biol (2011) 1.34

Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog (2012) 1.34

Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia. Nat Protoc (2006) 1.34

Identification of a gene cluster responsible for the biosynthesis of aurofusarin in the Fusarium graminearum species complex. Fungal Genet Biol (2005) 1.33

Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest (2007) 1.33

Mating, conidiation and pathogenicity of Fusarium graminearum, the main causal agent of the head-blight disease of wheat, are regulated by the MAP kinase gpmk1. Curr Genet (2003) 1.33

The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol (2011) 1.33

Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene. Mol Microbiol (2002) 1.31

Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol (2004) 1.29

Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis. Microbiology (2004) 1.29

Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol (2002) 1.27

The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata. Mol Microbiol (2008) 1.26

Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol (2010) 1.26

MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics (2009) 1.26

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One (2011) 1.25

Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol (2003) 1.25

Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy (2011) 1.24

Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology (2004) 1.23

CandidaDB: a genome database for Candida albicans pathogenomics. Nucleic Acids Res (2005) 1.23

Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother (2011) 1.21

Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure. J Virol (2002) 1.21

The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans. J Biol Chem (2006) 1.20

Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res (2004) 1.20

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells. Sci Signal (2013) 1.19

Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans. Antimicrob Agents Chemother (2006) 1.19

Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol (2013) 1.19

Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res (2009) 1.19

A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One (2009) 1.18

The quorum-sensing molecules farnesol/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicans. Eukaryot Cell (2011) 1.18

Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect (2011) 1.17

Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology (2006) 1.16

Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb Pathog (2002) 1.15